Institute of Sport Medicine and Science, Sport e Salute, Rome, Italy.
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy.
JAMA Cardiol. 2021 Jan 1;6(1):30-39. doi: 10.1001/jamacardio.2020.4306.
Paralympic medicine is a newly adopted term to describe the varied health care issues associated with athletes in the Paralympics. Scarce scientific data, however, are currently available describing the cardiac remodeling in Paralympic athletes.
To investigate the physiological and clinical characteristics of the Paralympic athlete's heart and derive the normative values.
DESIGN, SETTING, AND PARTICIPANTS: This is a single-center study on a relatively large cohort of Paralympic athletes, conducted at the Italian Institute of Sport Medicine and Science. Paralympic athletes free of cardiac or systemic pathologic conditions other than their cause of disability were selected for participation in the Paralympic Games from January 2000 to June 2014. Athletes were arbitrarily classified for disability in 2 groups: those with spinal cord injuries (SCI) and those with non-SCI (NSCI). Data analysis occurred from March 2019 to June 2020.
The primary outcome was the difference in cardiac remodeling in Paralympic athletes according to disability type and sports discipline type. Athletes underwent cardiac evaluation, including 12-lead and exercise electrocardiograms, echocardiography, and cardiopulmonary exercise testing.
Among 252 consecutive Paralympic athletes (median [interquartile range (IQR)] age, 34 [29-41] years; 188 men [74.6%]), 110 had SCI and 142 had NSCI. Those with SCI showed a higher prevalence of abnormal electrocardiogram findings than those with NSCI (13 of 110 [11.8%] vs 6 of 142 [4.2%]; P = .003), smaller left ventricular end-diastolic dimension (median [IQR], 48 [46-52] vs 51 [48-54] mm; P = .001) and left ventricular mass index (median [IQR], 80.6 [69-94] vs 91.3 [80-108] g/m2; P = .001), and lower peak oxygen uptake (VO2) (median [IQR], 27.1 [2-34] vs 38.5 [30-47] mL/min/kg; P = .001) in comparison with those with NSCI. Regarding sport discipline, endurance athletes had a larger left ventricular cavity (median [IQR], 52 [47-54] vs 49 [47-53] mm; P = .006) and higher peak VO2 (median [IQR], 46 [39-55] vs 30 [25-35] mL/min/kg; P = .001) than athletes in nonendurance sports.
Cardiac remodeling in Paralympic athletes differed by disability and sport discipline. Having NSCI lesions and engaging in endurance sports were associated with the largest left ventricular cavity and left ventricular mass and highest VO2 peak. Having SCI lesions and engaging in nonendurance disciplines, on the contrary, were associated with the smallest left ventricular cavity and mass and lowest VO2 peak.
残奥医学是一个新采用的术语,用于描述与残奥会运动员相关的各种医疗保健问题。然而,目前可用的关于残奥会运动员心脏重塑的科学数据很少。
研究残奥会运动员心脏的生理和临床特征,并得出正常值。
设计、地点和参与者:这是一项在意大利运动医学和科学研究所进行的、针对相对较大的残奥会运动员队列的单中心研究。选择无心脏或全身病理状况(除残疾原因外)的残奥会运动员参加 2000 年 1 月至 2014 年 6 月的残奥会。运动员根据残疾类型被任意分为 2 组:脊髓损伤(SCI)组和非脊髓损伤(NSCI)组。数据分析于 2019 年 3 月至 2020 年 6 月进行。
主要结果是根据残疾类型和运动项目类型,残奥会运动员心脏重塑的差异。运动员接受了心脏评估,包括 12 导联和运动心电图、超声心动图和心肺运动测试。
在 252 名连续的残奥会运动员中(中位数[四分位数范围(IQR)]年龄,34[29-41]岁;188 名男性[74.6%]),110 名患有 SCI,142 名患有 NSCI。与 NSCI 相比,SCI 运动员心电图异常的发生率更高(110 名中的 13 名[11.8%] vs 142 名中的 6 名[4.2%];P = .003),左心室舒张末期内径更小(中位数[IQR],48[46-52] vs 51[48-54] mm;P = .001)和左心室质量指数更低(中位数[IQR],80.6[69-94] vs 91.3[80-108] g/m2;P = .001),峰值摄氧量(VO2)更低(中位数[IQR],27.1[2-34] vs 38.5[30-47] mL/min/kg;P = .001)与 NSCI 相比。关于运动项目,耐力运动员的左心室腔更大(中位数[IQR],52[47-54] vs 49[47-53] mm;P = .006),峰值 VO2 更高(中位数[IQR],46[39-55] vs 30[25-35] mL/min/kg;P = .001),而非耐力运动运动员。
残奥会运动员的心脏重塑因残疾和运动项目而异。患有 NSCI 病变并从事耐力运动与最大的左心室腔和左心室质量以及最高的 VO2 峰值有关。相反,患有 SCI 病变并从事非耐力运动与最小的左心室腔和质量以及最低的 VO2 峰值有关。